United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of
Outcome
OIG enforcement action against United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of for false claims, kickbacks, controlled substance.
Details
United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of — OIG Enforcement (2012)
OIG took enforcement action against United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of in 2012 involving false claims, kickbacks, controlled substance violations in the Healthcare / General sector.
Violation types: False Claims, Kickbacks, Controlled Substance
Entity type: Healthcare Provider
Penalty type: Settlement
Source: United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of Paying Kickbacks and Engaging in Other Unlawful Practices to Promote Subsys, A Powerful Opioid Painkiller
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works